Aspirin vs Benralizumab
## Aspirin vs Benralizumab: Overview
This comparison examines the pharmacological differences between **Aspirin** and **Benralizumab**.
## Mechanism of Action
**Aspirin**: Irreversibly inhibits cyclooxygenase-1 and -2.
## Pharmacokinetics
**Half-life**: Aspirin — 2-3 hours; Benralizumab — N/A.
## Chemical Properties
**Molecular Formula**: Aspirin — C9H8O4; Benralizumab — N/A.
**Molecular Weight**: Aspirin — 180.1580 g/mol; Benralizumab — N/A.
**Type**: Aspirin — Small molecule; Benralizumab — Antibody.